鹿得医疗
(920278)
| 流通市值：0.00万 | | | 总市值：0.00万 |
| 流通股本：0.00万 | | | 总股本：0.00万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 133,362,208.22 | 61,093,741.9 | 344,603,098.61 | 234,676,473.81 |
| 营业收入 | 133,362,208.22 | 61,093,741.9 | 344,603,098.61 | 234,676,473.81 |
| 二、营业总成本 | 125,670,952 | 57,011,725.38 | 313,957,259.77 | 215,769,586.72 |
| 营业成本 | 99,280,167.97 | 44,536,747.54 | 257,427,204.61 | 175,847,183.36 |
| 税金及附加 | 1,671,558.88 | 1,136,026.09 | 2,973,369.72 | 2,382,308.68 |
| 销售费用 | 11,166,435.57 | 5,041,404.77 | 21,886,438.82 | 14,764,929.98 |
| 管理费用 | 10,084,909.93 | 4,450,250.99 | 22,293,272.6 | 14,598,990.31 |
| 研发费用 | 6,340,283.2 | 2,960,136.9 | 14,994,455.1 | 10,440,204.85 |
| 财务费用 | -2,872,403.55 | -1,112,840.91 | -5,617,481.08 | -2,264,030.46 |
| 其中:利息费用 | 563,142.1 | 253,314.2 | 389,316.18 | 187,405 |
| 其中:利息收入 | 1,591,417.76 | 679,517.88 | 2,733,943.52 | 1,942,205.98 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 603,334.93 | -61,705.27 | 110,451.54 | 505,855.59 |
| 加:投资收益 | -99,393.91 | -41,208.75 | 1,604,777.73 | 318,172.58 |
| 资产处置收益 | - | - | 13,125.32 | 13,008.82 |
| 资产减值损失(新) | 172,343.83 | 6,961.39 | -348,365.89 | 1,113,811.34 |
| 信用减值损失(新) | 2,232,669.52 | 2,877,616.57 | -2,729,005.1 | -997,450.62 |
| 其他收益 | 476,819.59 | 155,103.44 | 1,081,151.16 | 655,975.81 |
| 四、营业利润 | 11,077,030.18 | 7,018,783.9 | 30,377,973.6 | 20,516,260.61 |
| 加:营业外收入 | 46,382.66 | 25.38 | 5,494.75 | 5,491.45 |
| 减:营业外支出 | 269,369.05 | 1,605.89 | 171,198.83 | 159,151.18 |
| 五、利润总额 | 10,854,043.79 | 7,017,203.39 | 30,212,269.52 | 20,362,600.88 |
| 减:所得税费用 | 1,036,463.8 | 739,293.32 | 2,722,083.49 | 1,964,840.48 |
| 六、净利润 | 9,817,579.99 | 6,277,910.07 | 27,490,186.03 | 18,397,760.4 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 9,817,579.99 | 6,277,910.07 | 27,490,186.03 | 18,397,760.4 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 9,932,883.2 | 6,334,320.18 | 27,544,279.22 | 18,397,981.89 |
| 少数股东损益 | -115,303.21 | -56,410.11 | -54,093.19 | -221.49 |
| 扣除非经常损益后的净利润 | 9,217,787.71 | 6,253,230.2 | 26,207,980.39 | 17,538,088.68 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.06 | 0.04 | 0.16 | 0.11 |
| (二)稀释每股收益 | 0.06 | 0.04 | 0.16 | 0.11 |
| 八、其他综合收益 | -785.17 | - | - | - |
| 归属于母公司股东的其他综合收益 | -785.17 | - | - | - |
| 九、综合收益总额 | 9,816,794.82 | 6,277,910.07 | 27,490,186.03 | 18,397,760.4 |
| 归属于母公司股东的综合收益总额 | 9,932,098.03 | 6,334,320.18 | 27,544,279.22 | 18,397,981.89 |
| 归属于少数股东的综合收益总额 | -115,303.21 | -56,410.11 | -54,093.19 | -221.49 |
| 公告日期 | 2025-08-26 | 2025-04-25 | 2025-04-25 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |